









Markets
/
Stocks
/
nasdaq-wst
/

West Pharmaceutical Services Inc

WST

278.540USD

-6.320-2.22%

Close 10/30, 16:00（ET）Quotes delayed by 15 min

20.03BMarket Cap

40.73P/E TTM



West Pharmaceutical Services Inc

278.540

-6.320-2.22%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of West Pharmaceutical Services Inc

Currency: USD Updated: 2025-10-30

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

West Pharmaceutical Services Inc's Score

Industry at a Glance

Industry Ranking

28 / 210

Overall Ranking

91 / 4621

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 17 analysts

Buy

Current Rating

345.675

Target Price

+21.35%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

West Pharmaceutical Services Inc Highlights

StrengthsRisks

West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates through two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers packaging, containment solutions, and drug delivery products, along with analytical lab services and other integrated services and solutions, primarily to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 12.08%.

Stable Dividend

The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 12.08%.

Fairly Valued

The company’s latest PE is 41.02, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 70.72M shares, decreasing 3.44% quarter-over-quarter.

Held by Al Gore

Star Investor Al Gore holds 1.17M shares of this stock.

Lower Market Activity

The company has less investor interest, with a 20-day turnover ratio of -0.15.

Financial Health

Currency: USD Updated: 2025-10-30

The company's current financial score is 9.80, which is higher than the Healthcare Equipment & Supplies industry's average of 7.46. Its financial status is robust, and its operating efficiency is high. Its latest quarterly revenue reached 804.60M, representing a year-over-year increase of 7.73%, while its net profit experienced a year-over-year increase of 2.94%.

Score

Industry at a Glance

Previous score

9.80

Change



Financials

10.00

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

9.10

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

10.00

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.92

Key Metrics

Free cash flow

No Data

West Pharmaceutical Services Inc's Company Valuation

Currency: USD Updated: 2025-10-30

The company’s current valuation score is 4.45, which is lower than the Healthcare Equipment & Supplies industry's average of 7.19. Its current P/E ratio is 41.02, which is 44.21% below the recent high of 59.15 and 28.08% above the recent low of 29.50.

Score

Industry at a Glance

Previous score

4.45

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 28/210

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-30

The company’s current earnings forecast score is 8.13, which is higher than the Healthcare Equipment & Supplies industry's average of 7.74. The average price target for West Pharmaceutical Services Inc is 350.00, with a high of 375.00 and a low of 309.45.

Score

Industry at a Glance

Previous score

8.13

Change

Support & Resistance

No Data

Analyst Rating

Based on 17 analysts

Buy

Current Rating

345.675

Target Price

+21.35%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

110

Total

Median

Average

Company name

Ratings

Analysts

West Pharmaceutical Services Inc

WST

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-30

The company’s current price momentum score is 7.15, which is higher than the Healthcare Equipment & Supplies industry's average of 6.55. Sideways: Currently, the stock price is trading between the resistance level at 314.75 and the support level at 249.91, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.32

Change

-0.17

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(3)

Neutral(2)

Buy(1)

Indicators

Value

Direction

MACD(12,26,9)

0.476

Buy

RSI(14)

53.818

Neutral

STOCH(KDJ)(9,3,3)

27.915

Sell

ATR(14)

10.455

High Vlolatility

CCI(14)

13.441

Neutral

Williams %R

70.395

Sell

TRIX(12,20)

0.445

Sell

StochRSI(14)

0.000

Oversold

Moving Average

Sell(2)

Neutral(0)

Buy(4)

Indicators

Value

Direction

MA5

286.316

Sell

MA10

284.072

Sell

MA20

274.719

Buy

MA50

262.242

Buy

MA100

246.854

Buy

MA200

243.587

Buy

Institutional Confidence

Currency: USD Updated: 2025-10-30

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.43. The latest institutional shareholding proportion is 98.35%, representing a quarter-over-quarter decrease of 1.81%. The largest institutional shareholder is The Vanguard, holding a total of 9.28M shares, representing 12.90% of shares outstanding, with 4.35% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

9.28M

+0.90%

BlackRock Institutional Trust Company, N.A.

3.79M

-8.65%

State Street Investment Management (US)

3.27M

+2.13%

Brown Advisory

3.02M

-7.56%

Artisan Partners Limited Partnership

2.27M

+3.27%

Walter Scott & Partners Ltd.

2.20M

-6.07%

Geode Capital Management, L.L.C.

1.83M

-1.12%

APG Asset Management N.V.

1.66M

+6.18%

Van Eck Associates Corporation

1.49M

+2.65%

Generation Investment Management LLP

Star Investors

1.17M

+1304.91%

Risk Assessment

Currency: USD Updated: 2025-10-30

The company’s current risk assessment score is 6.38, which is higher than the Healthcare Equipment & Supplies industry's average of 4.57. The company's beta value is 1.09. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.